review Open AccessTop 1% cited
The incretin concept today
Diabetologia · 1979 · Vol. 16(2) · pp. 75–85
W. Creutzfeldt✉(University of Göttingen)
Diabetes Treatment and ManagementDiabetes Management and ResearchPharmacology and Obesity TreatmentIncretinPathogenesisInternal medicineMedicineEndocrinologyHormonePathologicalGastric inhibitory polypeptideType 2 diabetesDisease
Citations
731
FWCI
24.82
field-weighted impact
References
70
Percentile
100%
vs. same field & year
Citations per year
Cited by
Glucagon-like peptide 1 inhibition of gastric emptying outweighs its insulinotropic effects in healthy humans
American Journal of Physiology-Endocrinology and Metabolism · 1997 · 816 citations
Reduced incretin effect in Type 2 (non-insulin-dependent) diabetes
Diabetologia · 1986 · 1,298 citations
The Glucagon-Like Peptides
Endocrine Reviews · 1999 · 1,021 citations
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
Journal of Clinical Investigation · 1993 · 1,635 citations
Therapeutic potential of GLP-1 for treatment of diabetes
International journal of applied research · 2015 · 0 citations
Related articles
Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
Journal of Clinical Investigation · 1993 · 1,635 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.